Whalesbook Logo

Whalesbook

  • Home
  • About Us
  • Contact Us
  • News

Deepak Fertilisers Q2 Profit Flat, Revenue Grows 9% Amid Chemicals Segment Pressure

Chemicals

|

Updated on 05 Nov 2025, 04:05 pm

Whalesbook Logo

Reviewed By

Aditi Singh | Whalesbook News Team

Short Description :

Deepak Fertilisers and Petrochemicals Corporation Ltd (DFPCL) reported a consolidated net profit of ₹214 crore for the quarter ended September 2025, remaining nearly unchanged from the previous year. Revenue from operations increased by 9% year-on-year to ₹3,005.83 crore. While fertiliser and Technical Ammonium Nitrate (TAN) businesses performed strongly, the chemicals segment, particularly IPA, faced pressure due to global headwinds. The company also completed the full acquisition of its Australian subsidiary.
Deepak Fertilisers Q2 Profit Flat, Revenue Grows 9% Amid Chemicals Segment Pressure

▶

Stocks Mentioned :

Deepak Fertilisers and Petrochemicals Corporation Ltd

Detailed Coverage :

Deepak Fertilisers and Petrochemicals Corporation Ltd (DFPCL) announced its financial results for the quarter ending September 2025, reporting a consolidated net profit of ₹214 crore, which is largely flat compared to the same period last year. However, the company saw a healthy 9% rise in its revenue from operations, reaching ₹3,005.83 crore from ₹2,746.72 crore in the year-ago quarter.

Chairman and Managing Director S.C. Mehta attributed the performance to the company's strategic transformation and operational efficiency. The fertiliser and Technical Ammonium Nitrate (TAN) businesses were highlighted as key drivers of growth, showing strong performance.

Conversely, the chemicals segment experienced pressure. The IPA (Isopropyl Alcohol) business saw a significant 21% year-on-year decline due to global trade shifts, pricing volatility in benzene and acetone, and the impact of anti-dumping duties on Chinese imports, which increased US imports and squeezed margins. The ammonia segment also faced a volatile quarter, although recent price recovery above $400 per tonne and operational improvements offer a positive outlook. A planned shutdown in the fourth quarter is expected to boost capacity and save on natural gas costs.

Furthermore, DFPCL successfully completed the full acquisition of its Australian subsidiary, Platinum Blasting Services (PBS), which generated ₹533 crore in revenue and ₹80 crore in EBITDA in FY25.

Impact: This news has a mixed impact on investors. The robust performance in core segments like fertilisers and TAN is positive. However, the challenges faced by the chemicals segment, especially IPA, due to external global factors, could affect overall profitability and investor sentiment in the short term. The completion of the Australian subsidiary acquisition represents a strategic expansion for the company. Impact Rating: 6/10.

Difficult Terms: * Consolidated Net Profit: The total profit of a company including all its subsidiaries. * Revenue from Operations: The total income generated from the company's primary business activities. * Year-on-year (YoY): A comparison of a company's performance metric from the current period to the same period in the previous year. * Speciality Products: Products with unique chemical properties or compositions tailored for specific applications. * Operational Agility: The ability of a company to respond quickly and effectively to changes in its operational environment or market conditions. * Fertiliser: A chemical or natural substance added to soil or plants to supply essential nutrients for growth. * Technical Ammonium Nitrate (TAN): A chemical compound primarily used as an industrial explosive and as a component in fertilisers. * Global Headwinds: Unfavorable external economic or political conditions that impact businesses. * IPA (Isopropyl Alcohol): A common solvent and chemical intermediate used in various industries. * Ammonia: A colorless gas with a pungent odor, widely used in fertilisers, cleaning products, and industrial applications. * FOB (Free On Board): A shipping term where the seller is responsible for the goods until they are loaded onto the vessel, after which the buyer assumes risk and cost. * EBITDA: Earnings Before Interest, Taxes, Depreciation, and Amortization; a measure of a company's operating performance. * Anti-dumping duties: Tariffs imposed on imported goods sold at unfairly low prices to protect domestic industries.

More from Chemicals

Deepak Fertilisers Q2 Profit Flat, Revenue Grows 9% Amid Chemicals Segment Pressure

Chemicals

Deepak Fertilisers Q2 Profit Flat, Revenue Grows 9% Amid Chemicals Segment Pressure


Latest News

Piramal Finance Targets ₹1.5 Lakh Crore AUM by 2028, Plans ₹2,500 Crore Fundraising

Banking/Finance

Piramal Finance Targets ₹1.5 Lakh Crore AUM by 2028, Plans ₹2,500 Crore Fundraising

TeamLease Services Reports 11.8% Profit Growth to ₹27.5 Crore for Quarter Ended September 2025

Industrial Goods/Services

TeamLease Services Reports 11.8% Profit Growth to ₹27.5 Crore for Quarter Ended September 2025

India's Solar Manufacturing Faces Overcapacity Risk Amidst Export Challenges

Energy

India's Solar Manufacturing Faces Overcapacity Risk Amidst Export Challenges

Suzlon Energy Expands EPC Business to Sustain Growth, Aims to Double Share by FY28

Renewables

Suzlon Energy Expands EPC Business to Sustain Growth, Aims to Double Share by FY28

Global Markets Drop Amid Tech Selloff and Valuation Concerns

Tech

Global Markets Drop Amid Tech Selloff and Valuation Concerns

Indian State Refiners Post Massive Profit Surge Driven by Global Oil Prices and Strong Margins, Not Russian Discounts

Energy

Indian State Refiners Post Massive Profit Surge Driven by Global Oil Prices and Strong Margins, Not Russian Discounts


Healthcare/Biotech Sector

Sun Pharma Reports 2.56% Profit Growth in Q2 FY26; Revenue Reaches Rs 14,478 Crore

Healthcare/Biotech

Sun Pharma Reports 2.56% Profit Growth in Q2 FY26; Revenue Reaches Rs 14,478 Crore

Sun Pharma Reports 2.6% Profit Rise to ₹3,118 Cr in Q2, Driven by India and Emerging Markets; US Innovative Medicines Outpace Generics

Healthcare/Biotech

Sun Pharma Reports 2.6% Profit Rise to ₹3,118 Cr in Q2, Driven by India and Emerging Markets; US Innovative Medicines Outpace Generics


Real Estate Sector

TDI Infrastructure to Invest ₹100 Crore in TDI City, Kundli Project

Real Estate

TDI Infrastructure to Invest ₹100 Crore in TDI City, Kundli Project

M3M India Launches Gurgaon International City with ₹7,200 Crore Investment

Real Estate

M3M India Launches Gurgaon International City with ₹7,200 Crore Investment

More from Chemicals

Deepak Fertilisers Q2 Profit Flat, Revenue Grows 9% Amid Chemicals Segment Pressure

Deepak Fertilisers Q2 Profit Flat, Revenue Grows 9% Amid Chemicals Segment Pressure


Latest News

Piramal Finance Targets ₹1.5 Lakh Crore AUM by 2028, Plans ₹2,500 Crore Fundraising

Piramal Finance Targets ₹1.5 Lakh Crore AUM by 2028, Plans ₹2,500 Crore Fundraising

TeamLease Services Reports 11.8% Profit Growth to ₹27.5 Crore for Quarter Ended September 2025

TeamLease Services Reports 11.8% Profit Growth to ₹27.5 Crore for Quarter Ended September 2025

India's Solar Manufacturing Faces Overcapacity Risk Amidst Export Challenges

India's Solar Manufacturing Faces Overcapacity Risk Amidst Export Challenges

Suzlon Energy Expands EPC Business to Sustain Growth, Aims to Double Share by FY28

Suzlon Energy Expands EPC Business to Sustain Growth, Aims to Double Share by FY28

Global Markets Drop Amid Tech Selloff and Valuation Concerns

Global Markets Drop Amid Tech Selloff and Valuation Concerns

Indian State Refiners Post Massive Profit Surge Driven by Global Oil Prices and Strong Margins, Not Russian Discounts

Indian State Refiners Post Massive Profit Surge Driven by Global Oil Prices and Strong Margins, Not Russian Discounts


Healthcare/Biotech Sector

Sun Pharma Reports 2.56% Profit Growth in Q2 FY26; Revenue Reaches Rs 14,478 Crore

Sun Pharma Reports 2.56% Profit Growth in Q2 FY26; Revenue Reaches Rs 14,478 Crore

Sun Pharma Reports 2.6% Profit Rise to ₹3,118 Cr in Q2, Driven by India and Emerging Markets; US Innovative Medicines Outpace Generics

Sun Pharma Reports 2.6% Profit Rise to ₹3,118 Cr in Q2, Driven by India and Emerging Markets; US Innovative Medicines Outpace Generics


Real Estate Sector

TDI Infrastructure to Invest ₹100 Crore in TDI City, Kundli Project

TDI Infrastructure to Invest ₹100 Crore in TDI City, Kundli Project

M3M India Launches Gurgaon International City with ₹7,200 Crore Investment

M3M India Launches Gurgaon International City with ₹7,200 Crore Investment